1
0
0
News
Netzwerk-Profile
LinkedIn: Dietrich Tuerck – Nonclinical DMPK/PD project leader - LinkedInde.linkedin.com › dietrich-tuerck
Dietrich Tuerck. Nonclinical DMPK/PD project leader bei Roche. Roche. Lörrach, Baden-Württemberg, Deutschland. 61 Follower:innen 61 Kontakte.
LinkedIn: Dietrich Tuerck | LinkedIn
Sehen Sie sich das berufliche Profil von Dietrich Tuerck (Schweiz) auf LinkedIn an. LinkedIn ist das weltweit größte professionelle Netzwerk, das Fach- und ...
LinkedIn: Dietrich Tuerck | LinkedIn
Dietrich Tuercks berufliches Profil anzeigen LinkedIn ist das weltweit größte professionelle Netzwerk, das Fach- und Führungskräften wie Dietrich Tuerck dabei ...
LinkedIn: Dietrich Tuerck | LinkedIn
LinkedIn is the world's largest business network, helping professionals like Dietrich Tuerck discover inside connections to recommended job candidates, ...
Business-Profile
patentbuddy: Dietrich Tuerck
BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG, Ulm, DE
Ausbildung
Administration, distribution, metabolism and elimination of ...Scholars Portal Journals
journals.scholarsportal.info
Dietrich Tuerck · ORCID ID · Saileta Prabhu · ORCID ID · Leslie Dickmann · Jennifer Sims. Source Information. October 2014, Volume19(Issue10)Pages, p.1623To Dietrich Tuerck · ORCID ID · Saileta Prabhu · ORCID ID · Leslie Dickmann · Jennifer Sims. Source Information. October 2014, Volume19(Issue10)Pages, p.1623To
New challenges and opportunities in nonclinical safety ...Scholars Portal Journals
journals.scholarsportal.info
Authors. Andreas Baumann · ORCID ID · Dietrich Tuerck · ORCID ID · Saileta Prabhu · ORCID ID · Leslie Dickmann · Jennifer Sims. Source Information. October
Bücher
Investigating the effect of autoinduction in cynomolgus ...Taylor & Francis Online
www.tandfonline.com
von KJ Glenn · · Zitiert von: 11 — Dietrich Tuerck Roche Innovation Center, Basel, Switzerland. show all. Pages | Received 02 Sep 2015, Accepted 17 Oct 2015, Published online: 19 Nov ...
ALBERT — All Library Books, journals and Electronic Records ...KOBV
waesearch.kobv.de
... Dietrich Tuerck, Agnes Poirier, Wolfgang Muster, Stephan Kirchner, Lutz Mueller, Irene Gerlach and Friedrich Metzger. American Chemical Society (ACS). In Dietrich Tuerck, Agnes Poirier, Wolfgang Muster, Stephan Kirchner, Lutz Mueller, Irene Gerlach and Friedrich Metzger. American Chemical Society (ACS). In ...
Contemporary Technologies and the Morality of Warfare: The War of the...
books.google.co.uk
Supported by genuine historical cases, this book argues that certain new technologies in warfare can not only be justified within the current framework of the...
Xenobiotica: Vol 46, No 8Taylor & Francis Online
www.tandfonline.com
... Dietrich Tuerck. Pages: Published online: 19 Nov AbstractforInvestigating the effect of autoinduction in cynomolgus monkeys of a novel ...
Dokumente zum Namen
Discovery of a Potential Novel Medicine - ACS PublicationsACS Publications
pubs.acs.org
von H Ratni · · Zitiert von: 129 — Dietrich Tuerck,. †. Agnes Poirier,. †. Wolfgang Muster,. †. Stephan Kirchner,. †. Lutz Mueller,. †. Irene Gerlach,. † and Friedrich Metzger. †. von H Ratni · · Zitiert von: 129 — Dietrich Tuerck,. †. Agnes Poirier,. †. Wolfgang Muster,. †. Stephan Kirchner,. †. Lutz Mueller,. †. Irene Gerlach,. † and Friedrich Metzger. †.
FORSCHUNG/545: Neuer Wirkmechanismus SCHATTENBLICKwww.schattenblick.de › infopool › medizin › pharma
www.schattenblick.de
McAllister, Valerie Bertaina-Anglade, Christophe Drieu La Rochelle, Dietrich Tuerck, Annette Floesser, Beate Kiese, Michael Schumacher, Rainer Landgraf ...
Dose‐Proportional Pharmacokinetics of d‐threo ...Wiley
accp1.onlinelibrary.wiley.com
von D Tuerck · · Zitiert von: 20 — Dr Dietrich Tuerck PhD,. Dr Dietrich Tuerck PhD. Novartis Pharma AG, Exploratory Development, Drug Metabolism and Pharmacokinetics, Basel ... von D Tuerck · · Zitiert von: 20 — Dr Dietrich Tuerck PhD,. Dr Dietrich Tuerck PhD. Novartis Pharma AG, Exploratory Development, Drug Metabolism and Pharmacokinetics, Basel ...
2009_Polin_etal_science.pdfDrescher Lab
drescherlab.org
von M Polin · — Christophe Drieu La Rochelle,5 Dietrich Tuerck,6 Annette Floesser,4 Beate Kiese,7. Michael Schumacher,8 Rainer Landgraf,2 Florian Holsboer, von M Polin · — Christophe Drieu La Rochelle,5 Dietrich Tuerck,6 Annette Floesser,4 Beate Kiese,7. Michael Schumacher,8 Rainer Landgraf,2 Florian Holsboer,2 ...
Wissenschaftliche Veröffentlichungen
Drug Discovery Today | Vol 19, Issue 10, Pages (October...
www.sciencedirect.com
... metabolism and distribution of PEGs and PEGylated proteins: quo vadis? Andreas Baumann, Dietrich Tuerck, Saileta Prabhu, Leslie Dickmann, Jennifer Sims.
Translocator Protein (18 kD) as Target for Anxiolytics ...JSTOR
www.jstor.org
von R Rupprecht · · Zitiert von: 378 — Christophe Drieu La Rochelle,5 Dietrich Tuerck,6 Annette Floesser,4 Beate Kiese,7. Michael Schumacher,8 Rainer Landgraf,2 Florian Holsboer,2 Klaus Kucher4.
Translocator Protein (18 kD) as Target for Anxiolytics ...Science | AAAS
www.science.org
von R Rupprecht · · Zitiert von: 378 — ... Dietrich Tuerck, Annette Floesser, Beate Kiese, Michael Schumacher, Rainer Landgraf, Florian Holsboer, and Klaus Kucher+18 authors +
Pharmacokinetics, metabolism and distribution of PEGs ...ScienceDirect.com
www.sciencedirect.com
von A Baumann · · Zitiert von: 151 — Author links open overlay panel. Andreas Baumann 1 , Dietrich Tuerck 2 , Saileta Prabhu 3 , Leslie Dickmann 3 , Jennifer Sims 4. Show more. Add to Mendeley. von A Baumann · · Zitiert von: 151 — Author links open overlay panel. Andreas Baumann 1 , Dietrich Tuerck 2 , Saileta Prabhu 3 , Leslie Dickmann 3 , Jennifer Sims 4. Show more. Add to Mendeley.
Veröffentlichungen allgemein
Lack of UGT polymorphism association with idasanutlin...
link.springer.com
Idasanutlin is a selective small-molecule MDM2 antagonist. It activates the tumor suppressor TP53 and is in phase 3 clinical trial for acute myeloid leukem
org › publication
www.breenlab.org
· Audrey Ruple, Dietrich Tuerck, Jose A. Ramos-Vara, Liling Liu, Rodrigo Mohallem, Mark Merchant, Jackeline Franco, Christopher M. Fulkerson ...
Lack of UGT polymorphism association with idasanutlin ...Springer
link.springer.com
von WV So · · Zitiert von: 2 — The authors would like to thank Dietrich Tuerck for helpful discussion and acknowledge contributions from other Roche colleagues in the ... von WV So · · Zitiert von: 2 — The authors would like to thank Dietrich Tuerck for helpful discussion and acknowledge contributions from other Roche colleagues in the ...
Sonstiges
Molécules bispécifiques de liaison à l'antigène ciblant ox40 et fappatents.google.com › patent
patents.google.com
Dietrich Tuerck: Pablo Umaña: Joerg ZIELONKA; Original Assignee: F. Hoffmann-La Roche Ag: Hoffmann-La Roche Inc. Priority date (The priority date is an ...
NO B1 - Farmasoytisk sammensetning for oral ...Google Patents
patents.google.com
Dietrich Tuerck: Veit Schmelmer; Original Assignee: Boehringer Ingelheim Pharma; Priority date (The priority date is an assumption and is not a legal conclusion ... Dietrich Tuerck: Veit Schmelmer; Original Assignee: Boehringer Ingelheim Pharma; Priority date (The priority date is an assumption and is not a legal conclusion ...
Nye galeniske formuleringer av meloksicam for oral ...Google Patents
patents.google.com
Dietrich Tuerck: Thomas Bock: Paul Sagmueller: Peter Sieger. Worldwide applications EP. Application number: EP A. Filing date: Legal ...
Dietrich Tuerck's research worksResearchGate
www.researchgate.net
AP — Dietrich Tuerck's research while affiliated with Unilabs York Bioanalytical Solutions and other places · What is this page? · Publications (6) AP — Dietrich Tuerck's research while affiliated with Unilabs York Bioanalytical Solutions and other places · What is this page? · Publications (6) ...
搜索页_+Dietrich+Tuerck - 中国地质图书馆www.cglhub.com › auto › search
www.cglhub.com
... Dietrich Tuerck ; Agnes Poirier ; Wolfgang Muster ; Stephan Kirchner ; Lutz Mueller ; Irene Gerlach ; Friedrich Metzger. 刊名：Journal of Medicinal Chemistry.
A Case Study of theSMN2mRNA Splicing Modifier RisdiplamX-MOL
m.x-mol.com
... Dietrich Tuerck 1 , Mohammed Ullah 1 , Kenichi Umehara 1 , Agnès Poirier 2. Affiliations. Small molecules that present complex absorption, distribution ...
Accelerating Clinical Development of Idasanutlin through a ...Drug Metabolism & Disposition
dmd.aspetjournals.org
Kenichi Umehara, Yumi Cleary, Stephen Fowler, Neil Parrott and Dietrich Tuerck. Drug Metabolism and Disposition March 2022, 50 (3) ; DOI: https://doi ... Kenichi Umehara, Yumi Cleary, Stephen Fowler, Neil Parrott and Dietrich Tuerck. Drug Metabolism and Disposition March 2022, 50 (3) ; DOI: https://doi ...
Dose-proportional pharmacokinetics of d-threo-methylphenidate after a...
pubmed.ncbi.nlm.nih.gov
Authors. Dietrich Tuerck , Silke Appel-Dingemanse, Mojdeh Maboudian, Francoise Pommier, Yibin Wang, Greg Sedek. Affiliation. 1 Novartis Pharma AG, ...
A UGT2B10 Splicing Polymorphism Common in African ...University of Helsinki
researchportal.helsinki.fi
von S Fowler · · Zitiert von: 52 — Stephen Fowler, Heidemarie Kletzl, Moshe Finel, Nenad Manevski, Paul Schmid, Dietrich Tuerck, Roger D. Norcross, Marius C. Hoener, Olivia Spleiss, Victor A.
Accelerating Clinical Development of Idasanutlin through a OUCIouci.dntb.gov.ua › works
ouci.dntb.gov.ua
... Dietrich Tuerck. List of references. Bolleddula, PBPK modeling to predict drug–drug interactions of ivosidenib as a perpetrator in cancer patients and ...
A UGT2B10 Splicing Polymorphism Common in African Populations May...
jpet.aspetjournals.org
Stephen Fowler, Heidemarie Kletzl, Moshe Finel, Nenad Manevski, Paul Schmid, Dietrich Tuerck, Roger D. Norcross, Marius C. Hoener, Olivia ...
Autor: "Agnès Poirier"Politechnika Morska w Szczecinie
katalog.pm.szczecin.pl
Dietrich Tuerck · Christophe Husser · Mark Savage · Mohammed Ullah · Lutz Mueller · Yumi Cleary · Katja Heinig: Pokaż więcej; Temat: Pharmacology · Drug
Dose-proportional pharmacokinetics of d-threo-methylphenidate ...go.gale.com › i.do
go.gale.com
Gale OneFile includes Dose-proportional pharmacokinetics of d-threo-methylphe by Dietrich Tuerck, Silke Appel-Dingemanse. Click to explore.
Marius C Hoener - Publications List
publicationslist.org
Stephen Fowler, Heidemarie Kletzl, Moshe Finel, Nenad Manevski, Paul Schmid, Dietrich Tuerck, Roger D Norcross, Marius C Hoener, Olivia Spleiss, Victor A ...
CAS RG7800BOC Sciences
www.bocsci.com
... Dietrich Tuerck J Med Chem Jul 14;59(13): doi: acs.jmedchem.6b Spinal muscular atrophy (SMA) is the leading genetic cause of Dietrich Tuerck J Med Chem Jul 14;59(13): doi: acs.jmedchem.6b Spinal muscular atrophy (SMA) is the leading genetic cause of ,00 $
Find an Article, Find a Category, Find a Reference Citation Analysiswww.referencecitationanalysis.com › search
www.referencecitationanalysis.com
Dietrich Tuerck. Ranked By. Impact Index Per Article; Citation(s) in RCA. Results Analysis. Year Published Analysis; Article Type Analysis; Publication Title ...
Danièle Buchy | Scholar Profiles and RankingsScholarGPS
scholargps.com
Dietrich Tuerck (1). Dino Luethi (1). Gerhard Trube (1). Gregor Dernick (1). Guido Galley (1). Henri Stalder (1). Jean-Luc Moreau (1). Julian Reinisch (1).
Data from Phase I/II Trial of Vemurafenib in Dogs ...Figshare
figshare.com
Dietrich Tuerck. JR. José A. Ramos-Vara. LL. Liling Liu. RM. Rodrigo Mohallem. MM. Dietrich Tuerck. JR. José A. Ramos-Vara. LL. Liling Liu. RM. Rodrigo Mohallem. MM.
Figure S1 from Phase I/II Trial of Vemurafenib in Dogs with ...Figshare
figshare.com
posted on , 11:47 authored by Paul Rossman, Tanja S. Zabka, Audrey Ruple, Dietrich Tuerck, José A. Ramos-Vara, Liling Liu, Rodrigo Mohallem, ...
sortiert nach Relevanz / Datum